Literature DB >> 1174710

Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine.

E Müller-Schweinitzer, J Brundell.   

Abstract

Spiral strips from dog saphenous veins were contracted by 2.5 X 10(-9) M ergotamine, a concentration giving about 50% of maximal response. Phentolamine (3.6 X 10(-6) M) reduced these effects by 60% and indomethacin (2.8 X 10(-7) M) by 30%. Indomethacin was more effective in reducing ergotamine-induced increase of prostaglandin E-like activity in the bathing fluid than those induced by noradrenaline or potassium chloride. Arachidonic acid was more effective in increasing tension in ergotamine-stimulated than in noradrenaline- or potassium-stimulated veins. These findings suggest that the long-lasting venoconstrictor activity of ergotamine is mediated mainly by alpha-adrenoceptors but that enhanced formation of prostaglandin E-like substance(s) may also contribute.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174710     DOI: 10.1159/000158056

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  6 in total

1.  Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid production.

Authors:  B Lindblad; W E Burkel; T W Wakefield; L M Graham; J C Stanley
Journal:  Experientia       Date:  1988-03-15

2.  Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

3.  Actions of co-dergocrine mesylate and its components at vascular smooth muscle.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

4.  Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism.

Authors:  P D Henry; M Yokoyama
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

5.  Mechanisms of the ergonovine-induced vasoconstriction in the rabbit main coronary artery.

Authors:  A Suyama; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

6.  Ergotamine abuse and extra-hepatic portal hypertension.

Authors:  P E Fisher; D B Silk; N Menzies-Gow; M Dingle
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.